The next-generation sequencing library preparation market size was estimated at USD 2.45 billion in 2025 and is projected to increase from USD 2.77 billion in 2026 to approximately USD 8.47 billion by 2035, growing at a CAGR of 13.2% from 2026 to 2035. The Latin America region held a dominant position in the market with a share of 40.00% in 2025.The next-generation sequencing library preparation market is driven by the rise of precision and personalized medicine; the growing global burden of cancers and rare genetic disorders requires deeper genomic sequencing, and expanding applications in diagnostics.
Next-generation sequencing library preparations comprise critical workflow that converts raw DNA or RNA samples into sequenceable fragments. In clinical diagnostics and research, these optimized preparations offer benefits like improved sequencing coverage, enhanced cost-efficiency, and rapid screening of multiple targets simultaneously. This technology advances personalized medicine, oncology, and drug discovery by allowing high-throughput data extraction even from small biopsy samples.
To eliminate manual errors and increase throughput, laboratories are heavily adopting Automated NGS Library Preparation Systems. Automated workstations allow for precise, low-volume liquid handling that minimizes costly reagent waste while ensuring highly reproducible results.
Advancements in library preparation chemistries now enable successful sequencing from extremely limited or degraded samples, such as FFPE tissues or single cells. This trend is crucial for in-depth oncology profiling and rare disease diagnostics where sample material is inherently scarce.
Targeted sequencing panels are dominating the market share because they offer a highly cost-efficient and focused approach to identifying specific actionable mutations. This allows clinical and diagnostic laboratories to sequence relevant genes deeply rather than processing entire genomes, thereby reducing sequencing time and bioinformatics overhead.
AI and ML are revolutionizing the next-generation sequencing library preparation industry by enabling end-to-end wet-lab automation and drastically reducing manual errors. ML algorithms optimize critical upstream steps, such as sequence alignment and variant identification, while driving the development of high-throughput robotics for sample preparation. These intelligent systems enhance precision by lowering contamination risks and allowing for real-time monitoring of library quality. The laboratories can accelerate turnaround times, minimize reagent waste, and process low-input samples with higher success and reproducibility.
| Report Coverage | Details |
| Market Size in 2026 | USD 2.77 Billion |
| Market Size by 2035 | USD 8.47 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 13.2% |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Segments Covered | Sequencing Type, Product, Application, End-Use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Agilent Technologies, Inc., Integrated DNA Technologies, F. Hoffmann-La Roche AG, Inc., Illumina, Inc., Beckman Coulter Inc. (now part of Danaher Corporation), Becton, Merck KGaA, Dickinson and Company, New England Biolabs, Inc., PerkinElmer Inc., QIAGEN N.V., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Tecan Group Ltd. |
Rising Demand for Precision Medicine
The individualized therapies rely on accurate genetic profiling to target specific tumor mutations and rare disorders. To generate this highly accurate genomic data, patient DNA and RNA samples must first be converted into specific, sequencing-ready formats. Consequently, the growing clinical reliance on targeted therapies and companion diagnostics directly fuels the need for specialized, high-throughput, and automated library preparation workflows.
High Operational Cost
The market growth is hindered by restricting widespread adoption. The continuous need for specialized, expensive reagents, advanced laboratory equipment, and significant hands-on time from skilled personnel escalates overall NGS operational expenditures. Consequently, academic institutions, smaller research laboratories, and regional healthcare facilities with limited budgets face severe barriers to entry.
Targeted Sequencing Growth
The increasing demand for specialized target enrichment consumables, such as hybridization capture probes and amplicon panels. Because targeted methods sequence specific genomic regions rather than the entire genome, researchers require tailored library preparation workflows that isolate these regions before sequencing. This focused approach provides deeper coverage of disease-associated variants, making it the method of choice for routine oncology and clinical diagnostics
Why Did the Targeted Genome Sequencing Segment Hold a 4.00% Share for the Next-generation Sequencing Library Preparation Market?
The targeted genome sequencing segment held a dominant position in the market with a share of 40.00% in 2025. Owing to lower costs, faster turnaround times, and widespread adoption in oncology panels and precision medicine applications. By focusing on particular regions, targeted sequencing enables deeper sequencing coverage, making it highly sensitive to detecting rare mutations and structural variants.
The whole genome sequencing segment held a 28.00% share of the market in 2025, with momentum gaining as sequencing costs decline and demand rises for comprehensive genomic insights in research and rare disease studies. The increased utilization of WGS during infectious disease surveillance has driven a higher volume of samples processed and steady, recurring demand for library preparation consumables.
The whole exome sequencing segment held a 22.00% share of the market in 2025, with significantly less depth and fewer reagents than whole genome sequencing, presenting a highly cost-effective option for routine diagnostics and large-scale academic research. The reliance on specialized target enrichment and exome capture kits drives a sustained, high-volume demand for library preparation consumables and reagents.
The other sequencing types segment held a 10.00% share of the market in 2025, with surging demand for RNA-Seq for identifying gene isoforms, splicing variants, and complex biomarkers during large-scale drug discovery compound screenings. The rising importance of methylation sequencing in precision oncology, alongside high academic consumption of ChIP-Seq kits to map intricate protein-DNA interactions.
Why Did the Reagents & Consumables Segment Hold a 72.00% Share for the Next-generation Sequencing Library Preparation Market?
The reagents & consumables segment held a dominant position in the market with a share of 72.00% in 2025. Owing to its recurring usage across every sequencing run and the growing volume of NGS testing worldwide. The growing reliance on NGS in routine diagnostics, such as oncology, non-invasive prenatal testing, and infectious disease surveillance.
The instruments segment held a 28.00% share of the market in 2025, with the rapid integration of next-generation sequencing into oncology, rare disease diagnostics, and personalized medicine driving high demand for robust, accurate instrumentation. This synergy of advanced hardware, automated liquid handling, and clinical expansion establishes high-throughput instrumentation as a cornerstone of modern genomic infrastructure.
Why Did the Disease Diagnostics Segment Lead the Next-generation Sequencing Library Preparation Market?
The disease diagnostics segment registered its dominance over the market with a share of 42.00% in 2025, owing to expanding clinical adoption of NGS for oncology testing, rare disease detection, and personalized treatment decisions. Driving volume of precision oncology applications and high demand for targeted sequencing and panels.
The others segment held a 20.00% share of the market in 2025, with a rising adoption of advanced epigenetic methodologies, such as CHIP-Seq and Methyl-Seq, which are critical for uncovering complex disease mechanisms and discovering new drug targets. The steady influx of high-margin, flexible chemistries lowers operational barriers, unlocking new, highly profitable revenue streams across emerging industrial and forensic sectors.
Why Did the Academic and Research Institutions Segment Lead the Next-generation Sequencing Library Preparation Market?
The academic and research institutions segment registered its dominance over the market with a share of 36.00% in 2025, owing to extensive genomics research activities, government funding support, and large-scale sequencing projects. Research institutes frequently trial new sequencing methodologies, driving high-throughput adoption before these techniques are fully integrated into clinical or hospital workflows.
The pharmaceutical and biotechnology companies segment held a 30.00% share of the market in 2025, utilizing advanced library preparation workflows to identify novel drug targets and map out complex genetic disease mechanisms. This massive strategic shift toward precision medicine, where it is vital for developing targeted therapies that combat specific genetic mutations in oncology.
The hospitals and clinics segment held a 24.00% share of the market in 2025, due to gaining momentum as precision medicine initiatives increasingly integrate genomic testing into routine clinical care. The growing demand for early disease detection and routine clinical screening, which requires decentralized sequencing directly at the hospital level.
The others segment held a 10.00% share of the market in 2025, due to the integration of customizable chemistries into niche academic fields, such as agri-genomics and metagenomics, lowering operational barriers establishing highly versatile, profitable genomic sector.
Why Did the North America Region Lead the Next-generation Sequencing Library Preparation Market?
The North America region registered its dominance over the market with a share of 40.00% in 2025, owing to significant R&D investments, widespread clinical adoption of NGS technologies, and the presence of leading sequencing companies. Massive public and private funding directed toward cancer genomics, rare diseases, and population-wide sequencing studies heavily utilizes library preparation products.
U.S. Surgical Suture Market Trends
U.S. has a structural adoption heavily augmented by the widespread integration of antimicrobial coating that reduces surgical-site infections, directly lowering costly hospital readmissions and overall treatment expenses. The knotless barbed sutures are surging in popularity across orthopedic and plastic surgeries, eliminating manual tying to save critical operating room time.
The Europe region held the 18.10% share of the market in 2025, due to the sustained demand for library preparation consumables; high-volume consumption is accelerated by the rapid integration of next-generation sequencing workflows for oncology, companion diagnostics, and rare disease profiling within established molecular pathology infrastructures.
U.K. Surgical Suture Market Trends
The U.K. is eliminating the need for post-surgical removal and delivering superior healing outcomes across general, cardiovascular, and cosmetic surgeries. This product adoption is heavily reinforced by a distinct clinical shift toward antibacterial and antimicrobial-coated sutures to maximize patient safety and mitigate costly surgical site infections.
The Asia Pacific segment held a 23.00% share of the market in 2025, due to expanding sequencing infrastructure, rising healthcare expenditure, and large population-based genomics initiatives. Regional push for customized medical treatments, targeted therapies, and biomarker discovery necessitates large-scale sequencing, boosting library preparation workflows.
China Surgical Suture Market Trends
China’s eliminating secondary removal procedures, reducing patient trauma, and providing excellent healing outcomes across a surging volume of general, orthopedic, and cardiovascular surgeries. The synergy of expanding surgical volumes, advanced product engineering, and proactive state policy creates a highly dynamic and localized environment for rapid market expansion.
The Latin America region held a 5.00% share of the market in 2025, due to localized infrastructure growth and genomic surveillance networks that successfully reduce the region's historical reliance on outsourced international laboratories. The increased local accessibility, combined with targeted clinical research funding, drives a sustained, high-volume demand for advanced library preparation kits and consumables across the continent.
The MEA region held a 4.00% share of the market in 2025, due to high prevalence of cancer, rare genetic disorders, and recurrent viral outbreaks that require advanced diagnostic workflows. This clinical demand is heavily accelerated by proactive government-backed genomic initiatives and infrastructure developments across nations like Saudi Arabia and Kuwait to bolster localized precision medicine and reproductive health.
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has segmented the global Next-generation sequencing library preparation market.
Sequencing Type
Products
Application
End-use
By Region
Next-generation Sequencing Library Preparation Market
Download Sample
Request Customization
Request Customization
Download Sample